KLSE:SUPERMX

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Supermax Corporation Berhad

Market Cap

RM8.6b

Last Updated

2021/07/30 16:45 UTC

Data Sources

Company Financials +

Executive Summary

Supermax Corporation Berhad, an investment holding company, manufactures, distributes, and markets medical gloves and contact lenses in Malaysia. More Details


Snowflake Analysis

Flawless balance sheet with outstanding track record and pays a dividend.


Similar Companies

Share Price & News

How has Supermax Corporation Berhad's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: SUPERMX is not significantly more volatile than the rest of MY stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: SUPERMX's weekly volatility (8%) has been stable over the past year.


Market Performance


7 Day Return

-10.9%

SUPERMX

-6.5%

MY Medical Equipment

-1.0%

MY Market


1 Year Return

-64.6%

SUPERMX

-60.3%

MY Medical Equipment

-0.7%

MY Market

Return vs Industry: SUPERMX underperformed the MY Medical Equipment industry which returned -60.3% over the past year.

Return vs Market: SUPERMX underperformed the MY Market which returned -0.7% over the past year.


Shareholder returns

SUPERMXIndustryMarket
7 Day-10.9%-6.5%-1.0%
30 Day-1.2%-3.6%-0.4%
90 Day-45.8%-31.9%-5.9%
1 Year-63.4%-64.6%-57.5%-60.3%3.0%-0.7%
3 Year211.0%195.9%88.7%72.7%-2.8%-12.0%
5 Year579.5%511.2%341.7%288.8%9.8%-8.7%

Long-Term Price Volatility Vs. Market

How volatile is Supermax Corporation Berhad's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Supermax Corporation Berhad undervalued compared to its fair value and its price relative to the market?

8.2%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: SUPERMX (MYR3.27) is trading below our estimate of fair value (MYR3.56)

Significantly Below Fair Value: SUPERMX is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: SUPERMX is good value based on its PE Ratio (2.6x) compared to the MY Medical Equipment industry average (3.8x).

PE vs Market: SUPERMX is good value based on its PE Ratio (2.6x) compared to the MY market (17.1x).


Price to Earnings Growth Ratio

PEG Ratio: SUPERMX's earnings are forecast to decline next year, so we can't calculate its PEG ratio.


Price to Book Ratio

PB vs Industry: SUPERMX is good value based on its PB Ratio (2.1x) compared to the MY Medical Equipment industry average (2.6x).


Future Growth

How is Supermax Corporation Berhad forecast to perform in the next 1 to 3 years based on estimates from 10 analysts?

-48.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: SUPERMX's earnings are forecast to decline over the next 3 years (-48.6% per year).

Earnings vs Market: SUPERMX's earnings are forecast to decline over the next 3 years (-48.6% per year).

High Growth Earnings: SUPERMX's earnings are forecast to decline over the next 3 years.

Revenue vs Market: SUPERMX's revenue is expected to decline over the next 3 years (-18.1% per year).

High Growth Revenue: SUPERMX's revenue is forecast to decline over the next 3 years (-18.1% per year).


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: SUPERMX's Return on Equity is forecast to be low in 3 years time (11%).


Past Performance

How has Supermax Corporation Berhad performed over the past 5 years?

86.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: SUPERMX has high quality earnings.

Growing Profit Margin: SUPERMX's current net profit margins (52.3%) are higher than last year (8.6%).


Past Earnings Growth Analysis

Earnings Trend: SUPERMX's earnings have grown significantly by 86.8% per year over the past 5 years.

Accelerating Growth: SUPERMX's earnings growth over the past year (2217.2%) exceeds its 5-year average (86.8% per year).

Earnings vs Industry: SUPERMX earnings growth over the past year (2217.2%) exceeded the Medical Equipment industry 41.4%.


Return on Equity

High ROE: SUPERMX's Return on Equity (78.6%) is considered outstanding.


Financial Health

How is Supermax Corporation Berhad's financial position?


Financial Position Analysis

Short Term Liabilities: SUPERMX's short term assets (MYR5.4B) exceed its short term liabilities (MYR2.7B).

Long Term Liabilities: SUPERMX's short term assets (MYR5.4B) exceed its long term liabilities (MYR169.4M).


Debt to Equity History and Analysis

Debt Level: SUPERMX's debt to equity ratio (7.2%) is considered satisfactory.

Reducing Debt: SUPERMX's debt to equity ratio has reduced from 39.3% to 7.2% over the past 5 years.

Debt Coverage: SUPERMX's debt is well covered by operating cash flow (1482.5%).

Interest Coverage: SUPERMX's interest payments on its debt are well covered by EBIT (389x coverage).


Balance Sheet


Dividend

What is Supermax Corporation Berhad current dividend yield, its reliability and sustainability?

2.32%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: SUPERMX's dividend (2.32%) is higher than the bottom 25% of dividend payers in the MY market (1.49%).

High Dividend: SUPERMX's dividend (2.32%) is low compared to the top 25% of dividend payers in the MY market (4.17%).


Stability and Growth of Payments

Stable Dividend: SUPERMX's dividend payments have been volatile in the past 10 years.

Growing Dividend: SUPERMX's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its low payout ratio (3%), SUPERMX's dividend payments are thoroughly covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: SUPERMX's dividends in 3 years are forecast to be well covered by earnings (34.6% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.5yrs

Average board tenure


CEO

Supermax Corporation Berhad has no CEO, or we have no data on them.


Board Members

Experienced Board: SUPERMX's board of directors are considered experienced (3.5 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Supermax Corporation Berhad's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Supermax Corporation Berhad
  • Ticker: SUPERMX
  • Exchange: KLSE
  • Founded: 1987
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: RM8.560b
  • Shares outstanding: 2.62b
  • Website: https://www.supermax.com.my

Location

  • Supermax Corporation Berhad
  • Lot 38, Putra Industrial Park
  • Bukit Rahman Putra
  • Sungai Buloh
  • Selangor
  • 47000
  • Malaysia

Listings


Biography

Supermax Corporation Berhad, an investment holding company, manufactures, distributes, and markets medical gloves and contact lenses in Malaysia. The company offers various types of natural rubber and nitr...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/07/30 16:45
End of Day Share Price2021/07/30 00:00
Earnings2021/03/31
Annual Earnings2020/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.